Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension clinical trial (NCT03897868). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my blood pressure be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension clinical trial (NCT03897868). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from HCP1803 or the other treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension clinical trial (NCT03897868). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension clinical trial (NCT03897868). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks involved with switching to a new medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension clinical trial (NCT03897868). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if my blood pressure does not improve during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension clinical trial (NCT03897868). Contact the study team or your healthcare provider for specific answers.

What this study is about